Vistagen Therapeutics, Inc. (NASDAQ:VTGN) showed up in the 13F filings of 1 institutional investors as of June 2024.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,060,000 | 0 | 0.00% | $2,025,414.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,060,000 | 0 | 0.00% | $2,025,414.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,060,000 | 0 | 0.00% | $2,025,414.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,060,000 | 0 | 0.00% | $2,025,414.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 3,060,000 | 0 | 0.00% | $2,025,414.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 2,676,580 | 0 | 0.00% | $1,771,628.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 2,676,580 | 0 | 0.00% | $1,771,628.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 2,676,580 | 0 | 0.00% | $1,771,628.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 2,676,580 | 0 | 0.00% | $1,771,628.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 2,676,580 | 0 | 0.00% | $1,771,628.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,824,738 | 137,003 | 8.12% | $1,207,977.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,824,738 | 137,003 | 8.12% | $1,207,977.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,824,738 | 137,003 | 8.12% | $1,207,977.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,824,738 | 137,003 | 8.12% | $1,207,977.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,824,738 | 137,003 | 8.12% | $1,207,977.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 1,247,150 | 1,134,088 | 1,003.07% | $825,488.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 1,247,150 | 1,134,088 | 1,003.07% | $825,488.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 1,247,150 | 1,134,088 | 1,003.07% | $825,488.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 1,247,150 | 1,134,088 | 1,003.07% | $825,488.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 1,247,150 | 1,134,088 | 1,003.07% | $825,488.00 |